The ODYSSEY DM-DYSLIPIDEMIA trial: Confirming the benefits of alirocumab in diabetic mixed dyslipidemia

Paul Chan, Li Shao, Brian Tomlinson, Zhong Min Liu

Research output: Contribution to journalEditorialpeer-review

Fingerprint Dive into the research topics of 'The ODYSSEY DM-DYSLIPIDEMIA trial: Confirming the benefits of alirocumab in diabetic mixed dyslipidemia'. Together they form a unique fingerprint.